Referenced Citations Ahrn, B., et al., Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
Central to this plan is the emphasis on eating smaller, balanced meals that are rich in nutritional value but lower in calories
For a detailed comparison across multiple dimensions, the semaglutide versus tirzepatide versus retatrutide comparison offers comprehensive analysis
Brand names: Mounjaro (diabetes), Zepbound (obesity)
If your blood glucose exceeds 240 mg/dL, check for ketones, especially if you have type 1 diabetes or are insulin-dependent
This often requires conscious effort and protein-first meal planning